Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (4) , 558-562
- https://doi.org/10.1016/s0959-8049(98)00429-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trialThe Lancet, 1996
- Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patientsThe Lancet, 1995
- Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.Journal of Clinical Oncology, 1993
- Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.Journal of Clinical Oncology, 1992
- Effects of preoperative chemotherapy on gastric adenocarcinomas. A morphologic study of 25 casesCancer, 1992
- Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapyCancer, 1991
- Improving results in the treatment of gastric cancer: An 11-year auditBritish Journal of Surgery, 1991
- Adenocarcinoma of the stomach: A review of 35 years and 1,710 casesWorld Journal of Surgery, 1990
- Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1989
- Gastric AdenocarcinomaArchives of Surgery, 1989